Title       : Adaptive Control of Drug Delivery Based on Sparse Measure- ments: Recursive
               Bayesian Estimation Forecasting and Sampling
Type        : Award
NSF Org     : BES 
Latest
Amendment
Date        : January 21,  1994   
File        : a9210341

Award Number: 9210341
Award Instr.: Standard Grant                               
Prgm Manager: K. M. Mudry                             
	      BES  DIV OF BIOENGINEERING & ENVIRON SYSTEMS 
	      ENG  DIRECTORATE FOR ENGINEERING             
Start Date  : September 1,  1992  
Expires     : February 28,  1995   (Estimated)
Expected
Total Amt.  : $70000              (Estimated)
Investigator: Thomas C. Jannett   (Principal Investigator current)
Sponsor     : U of Alabama Birmingham
	      AB 1170
	      Birmingham, AL  352940111    205/934-5266

NSF Program : 5345      BIOMEDICAL ENGINEERING
Fld Applictn: 0203000   Health                                  
              59        Engineering NEC                         
Program Ref : 
Abstract    :
              The goal of this project is the                                                
              development of an algorithm for                                                
              real-time adaptive control of drug                                             
              delivery based on sparse                                                       
              measurements of a patient's                                                    
              responses.  It will involve                                                    
              recursive Bayesian parameter                                                   
              estimation, forecasting the                                                    
              expected                                                                       
              performance of adaptive control,                                               
              and the determination of an                                                    
              appropriate sampling schedule.  The                                            
              algorithm will be validated                                                    
              using Monte Carlo simulations of                                               
              adaptive control based on sparse                                               
              measurements for several                                                       
              representative clinical                                                        
              applications.                                                                  
              This research is important since it                                            
              could form the basis for new,                                                  
              innovative drug delivery technology                                            
              that will offer significant                                                    
              advantages over current technology.                                            
              This system should allow                                                       
              patient response to be controlled                                              
              more accurately than with model                                                
              based open-loop control.
